Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis

XA Phi, MJW Greuter, Inge-marie Obdeijn, JC Oosterwijk, TL Feenstra, N Houssami, GH de Bock

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)82-88
Number of pages7
JournalBreast
Volume45
DOIs
Publication statusPublished - 2019

Cite this